FIELD: medicine.
SUBSTANCE: pharmaceutical composition in a pressed tableted form contains parathyroid hormone (PTH), 5-CNAC or its salt, a disintegrant and a solvent. A disintegration time of the composition makes no more than 6 min, while solubility more than 90% takes place for 20 min.
EFFECT: group of inventions provides effective PHT delivery; a tablet is rapidly disintegrated or dissolved, and the active ingredient has a therapeutic effect.
10 cl, 7 ex, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF CALCITONIN FOR TREATING RHEUMATOID ARTHRITIS | 2006 |
|
RU2453330C2 |
| CALCITONIN USED AT OSTEOARTHRITIS | 2004 |
|
RU2368390C2 |
| PHARMACEUTICAL COMPOSITIONS FOR PERORAL INTAKE OF PHARMACOLOGICAL ACTIVE SUBSTANCES | 2001 |
|
RU2287999C2 |
| ORAL ADMINISTRATION OF PARATHYROID HORMONE AND CALCITONIN | 2002 |
|
RU2300392C2 |
| 5-CNAC AS AGENT FOR ORAL DELIVERY OF PARATHYROID HORMONE FRAGMENTS | 2002 |
|
RU2322256C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING HGH FOR ORAL ADMINISTRATION | 2007 |
|
RU2493868C2 |
| CRYSTALLINE FORMS OF DISODIUM SALT OF N-(5-CHLOROSALICILOUL-)-8-AMINOCAPRYLIC ACID | 2006 |
|
RU2507196C2 |
| PERORAL INTRODUCTION OF CALCITONIN | 2003 |
|
RU2355417C2 |
| PEPTIDE ANALOGS FOR TREATMENT OF DISEASES AND DISORDERS | 2012 |
|
RU2616511C2 |
| MIMETIC CALCITONIN FOR TREATING DISEASES AND DISORDERS | 2014 |
|
RU2689551C1 |
